Role of VEGF in developmental angiogenesis and in tumor angiogenesis in the brain - PubMed

Review

Role of VEGF in developmental angiogenesis and in tumor angiogenesis in the brain

Marcia Regina Machein et al. Cancer Treat Res. 2004.

Similar articles

• Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.

  Shibuya M. Shibuya M. FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31. FEBS J. 2009. PMID: 19664071 Review.

• New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya.

  Lim M, Cheshier S, Steinberg GK. Lim M, et al. Curr Neurovasc Res. 2006 Aug;3(3):237-45. doi: 10.2174/156720206778018730. Curr Neurovasc Res. 2006. PMID: 16918387 Review.

• Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo.

  Wang P, Zhen H, Zhang J, Zhang W, Zhang R, Cheng X, Guo G, Mao X, Wang J, Zhang X. Wang P, et al. Mol Carcinog. 2012 Jul;51(7):586-95. doi: 10.1002/mc.20829. Epub 2011 Jul 14. Mol Carcinog. 2012. PMID: 21761458

• The role of VEGF in the regulation of physiological and pathological angiogenesis.

  Ferrara N. Ferrara N. EXS. 2005;(94):209-31. doi: 10.1007/3-7643-7311-3_15. EXS. 2005. PMID: 15617481 Review. No abstract available.

• Antiangiogenic therapy for primary and metastatic brain tumors.

  Purow B, Fine HA. Purow B, et al. Hematol Oncol Clin North Am. 2004 Oct;18(5):1161-81, x. doi: 10.1016/j.hoc.2004.05.003. Hematol Oncol Clin North Am. 2004. PMID: 15474340 Review.

Cited by

• Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy.

  Hebron ML, Lonskaya I, Olopade P, Selby ST, Pagan F, Moussa CE. Hebron ML, et al. J Clin Cell Immunol. 2014 Sep 30;5:259. doi: 10.4172/2155-9899.1000259. J Clin Cell Immunol. 2014. PMID: 25635231 Free PMC article.

• Angiopoietin-2 induces the neuronal differentiation of mouse embryonic NSCs via phosphatidylinositol 3 kinase-Akt pathway-mediated phosphorylation of mTOR.

  Zhou H, Wei M, Lu L, Chu T, Li X, Fu Z, Liu J, Kang Y, Liu L, Lou Y, Zhang C, Gao Y, Kong X, Feng S. Zhou H, et al. Am J Transl Res. 2019 Mar 15;11(3):1895-1907. eCollection 2019. Am J Transl Res. 2019. PMID: 30972213 Free PMC article.

• Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells.

  Grau S, Thorsteinsdottir J, von Baumgarten L, Winkler F, Tonn JC, Schichor C. Grau S, et al. J Neurooncol. 2011 Aug;104(1):103-12. doi: 10.1007/s11060-010-0480-6. Epub 2011 Feb 11. J Neurooncol. 2011. PMID: 21308397

• Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.

  Mishima Y, Terui Y, Sugimura N, Matsumoto-Mishima Y, Rokudai A, Kuniyoshi R, Hatake K. Mishima Y, et al. Cancer Sci. 2007 Mar;98(3):364-72. doi: 10.1111/j.1349-7006.2007.00393.x. Cancer Sci. 2007. PMID: 17270026 Free PMC article.

• Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction.

  Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y. Zhao T, et al. Microvasc Res. 2010 Sep;80(2):188-94. doi: 10.1016/j.mvr.2010.03.014. Epub 2010 Apr 1. Microvasc Res. 2010. PMID: 20362592 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information